Our roots are in one of America’s great entrepreneurial success stories. Fidelity Investments was founded in 1946 and grew from a single mutual fund into one of the largest asset management firms in the world, with over $2 trillion in assets under management. For the last forty years, our venture capital group has had the privilege of backing other great entrepreneurs as they built ground-breaking companies in technology and life sciences, including Atari, MCI, ROLM Corp., Alibaba, Ironwood Pharmaceuticals, and Ultragenyx. Today our funds are larger and more global, but our teams are still small and local. We stay true to our entrepreneurial roots. In the US and Europe, we are F-Prime Capital investing in healthcare (formerly Fidelity Biosciences) and in technology (formerly part of Devonshire Investors). In other geographies, our sister fund is called Eight Roads (formerly Fidelity Growth Partners), with investment teams in London, Shanghai, Beijing, Hong Kong, Tokyo, and Mumbai. Together we bring a world of insight, domain expertise and relationships to support our entrepreneurs. Without the pressure of fundraising from outside investors, we focus all of our time finding and helping great entrepreneurs build important companies.
我们正在追踪 F-Prime 的市场扩张
F-Prime 的国际扩张与竞争对手的对比情况
F-Prime你条形图显示所对比公司之间的相对规模。
列5| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
 F-Prime你 | 0 | 0 | — | 0 | 0 |
当前没有招聘
注册以跟踪该公司，并在发生变化时第一时间获得提醒。
没有进行中的营销活动
注册以跟踪该公司，并在发生变化时第一时间获得提醒。
FDA授予OnCusp Therapeutics的CUSP06快速通道资格，用于治疗铂耐药性卵巢癌，加速开发这种有前景的疗法。
拉丁美洲金融科技公司 Toku 获得由 Oak HC/FT 领投的 4800 万美元 A 轮融资，总融资额达 5500 万美元。
波士顿的Almanac Health获得由F-Prime领投的1000万美元种子轮融资,General Catalyst和Lightspeed参与,总融资额达1200万美元,用于其临床AI平台。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 F-Prime 的业务、市场和增长信号的快速解答。
